NDC 68462-435 – Acamprosate Calcium
Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · Oral
Product NDC68462-435
Product details
- Brand name
- Acamprosate Calcium
- Generic name
- Acamprosate Calcium
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Dosage form
- Tablet, Delayed Release
- Route
- Oral
- Marketing category
- ANDA · ANDA202229
- Marketed since
- July 16, 2013
- Listing expires
- December 31, 2027
Active ingredients
- Acamprosate Calcium 333 mg/1
Uses, dosage, side effects and warnings for Acamprosate Calcium →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 68462-435-11 | 10 BLISTER PACK in 1 CARTON (68462-435-11) / 10 TABLET, DELAYED RELEASE in 1 BLISTER PACK | Jul 16, 2013 |
| 68462-435-18 | 180 TABLET, DELAYED RELEASE in 1 BOTTLE (68462-435-18) | Jul 16, 2013 |
Other Acamprosate Calcium products
- 60687-121 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · American Health Packaging
- 69452-353 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · Bionpharma Inc.,
- 0904-7213 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · Major Pharmaceuticals
- 0378-6333 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · Mylan Pharmaceuticals Inc.
- 0615-8560 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · NCS HealthCare of KY, LLC dba Vangard Labs
- 0615-8660 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · NCS HealthCare of KY, LLC dba Vangard Labs
- 70518-4616 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · REMEDYREPACK INC.
- 70069-860 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · Somerset Therapeutics, LLC
- 70771-1057 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · Zydus Lifesciences Limited
- 68382-569 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · Zydus Pharmaceuticals (USA) Inc.